SLAM
GMED icon

Swiss Life Asset Management’s Globus Medical GMED Stock Holding History

Swiss Life Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$803K Buy
10,167
+20
+0.2% +$1.7K ﹤0.01% 768
2026
Q1 		$874K Buy
10,147
+1,941
+24% +$174K ﹤0.01% 683
2025
Q4 		$716K Buy
8,206
+3,021
+58% +$229K ﹤0.01% 704
2025
Q3 		$297K Buy
+5,185
New +$299K ﹤0.01% 916

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Swiss Life Asset Management's GMED Position: Q2 2026 in Review

Swiss Life Asset Management increased its Globus Medical (GMED) stake by 0.2% in Q2 2026, buying an estimated $1.7K and bringing the position to 10,167 shares worth $803K. The position accounts for ﹤0.01% of the portfolio, ranked #768.

Swiss Life Asset Management first reported a position in GMED in Q3 2025 and has held it in 4 quarters since. The position peaked at $874K in Q1 2026. 486 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Swiss Life Asset Management held 10,167 shares of Globus Medical worth $803K as of Q2 2026.
  • Swiss Life Asset Management bought 20 Globus Medical shares in Q2 2026, an estimated $1.7K.
  • Globus Medical made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #768 holding.
  • Swiss Life Asset Management first reported a position in Globus Medical in Q3 2025 and has held it in 4 quarters since.
  • Swiss Life Asset Management's Globus Medical position peaked at $874K in Q1 2026.
  • 486 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.